The phrase “patient capital” gets used a lot in venture circles. Usually it’s positioning — a fund saying it won’t pressure founders to exit on a timeline that suits the fund life rather than the business. Most of the time it’s marketing copy. Sometimes it’s...
Getting to a term sheet is hard. Getting through due diligence is where most deals die — not because founders can’t answer the questions, but because they didn’t know the questions were coming. This isn’t a problem of competence. Most Southeast Asian founders who lose...
There’s a quiet reallocation happening in Southeast Asian venture capital right now, and most founders and fund watchers are missing it because they’re looking at the wrong data. The headline number — seed funding in SEA down roughly 50% from its 2022 peak — tells...
Most fund managers spend 80% of their time thinking about deals — sourcing, diligence, term sheets, portfolio support. LPs spend 80% of their evaluation time thinking about the fund manager. Not the portfolio. Not the thesis slide. The person and the team writing the checks....
Cap table management doesn’t get discussed nearly enough in Southeast Asia’s founder community — until it starts killing rounds. We’ve sat across the table from founders raising Series A and B who had done everything right in their business but had cap tables that made...
Most founders prepare a deck. Few prepare what matters before the deck opens. You spent three weeks on your pitch deck. You rehearsed the delivery. You got the intro. Here’s what we did before your calendar invite even landed: we Googled you. Then we looked...
There is a particular kind of investor who has done everything right on paper. They have diversified across asset classes. They have parked capital in index funds, blue-chip equities, REITs, maybe a handful of bonds. Their portfolio looks balanced, conservative, and — on the surface...
A toxic complacency has formed within the boardrooms of Singapore, the skyscraper offices of Dubai, and the family offices of Palo Alto. Many sophisticated investors feel safe and secure they have gotten through the storm. On their diversified portfolios, they see large paper gains on...
The technology industry’s crying relief has gone ‘awe inspiring’, having gone through the trials and tribulations of 2022 and 2023, the prevailing argument at present is that the bear market is dead with whatever optimism exists is very tentative for an impending recovery. The technology...
A Tale of Two Markets: AI Feasting & Selective Climate Tech Remember when “diversification” meant trailing bets in fintech, SaaS or maybe some biotech? Simpler times. If you’re viewing the Q3 2025 numbers as we are, you’re feeling two competing emotions: breathless awe at AI’s...
